β2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration

Neuropharmacology

Volumn 47, Issue SUPPL. 1, 2004, Pages 132-139

  King, Sarah L ^a   Caldarone, Barbara J ^a   Picciotto, Marina R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral sensitization; Dopamine; Knockout mice; nAChR; Pimozide

Indexed keywords

DOPAMINE; DRINKING WATER; NICOTINE; NICOTINIC RECEPTOR; PIMOZIDE; COTININE; NICOTINIC AGENT; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BETA CHAIN; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; CIRCADIAN RHYTHM; DRUG EFFECT; MOTOR ACTIVITY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; CIRCADIAN RHYTHM; COTININE; DOPAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PIMOZIDE; RECEPTORS, NICOTINIC;

EID: 4644314873     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.06.024     Document Type: Article

References (38)

1. Benwell M.E., Balfour D.J. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. British Journal of Pharmacology. 105:1992;849-856
2. Champtiaux N., Han Z.Y., Bessis A., Rossi F.M., Zoli M., Marubio L., McIntosh J.M., Changeux J.P. Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. Journal of Neuroscience. 22:2002;1208-1217
3. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., Clementi F., Moretti M., Rossi F.M., Le Novere N., McIntosh J.M., Gardier A.M., Changeux J.P. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. Journal of Neuroscience. 23:2003;7820-7829
4. Clarke P.B., Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. British Journal of Pharmacology. 78:1983;329-337
5. Clarke P.B., Fu D.S., Jakubovic A., Fibiger H.C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. Journal of Pharmacology and Experimental Therapeutics. 246:1988;701-708
6. Cui C., Booker T.K., Allen R.S., Grady S.R., Whiteaker P., Marks M.J., Salminen O., Tritto T., Butt C.M., Allen W.R., Stitzel J.A., McIntosh J.M., Boulter J., Collins A.C., Heinemann S.F. The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. Journal of Neuroscience. 23:2003;11045-11053
7. Damaj M.I., Martin B.R. Is the dopaminergic system involved in the central effects of nicotine in mice? Psychopharmacology. 111:1993;106-108
8. Gaddnas H., Pietila K., Ahtee L. Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice. Behavioural Brain Research. 113:2000;65-72
9. Gaddnas H., Pietila K., Piepponen T.P., Ahtee L. Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water. Pharmacology, Biochemistry and Behavior. 70:2001;497-503
10. Grady S.R., Meinerz N.M., Cao J., Reynolds A.M., Picciotto M.R., Changeux J.P., McIntosh J.M., Marks M.J., Collins A.C. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. Journal of Neurochemistry. 76:2001;258-268
11. Green T.A., Brown R.W., Phillips S.B., Dwoskin L.P., Bardo M.T. Locomotor stimulant effects of nornicotine: role of dopamine. Pharmacology Biochemistry and Behavior. 74:2002;87-94
12. Grottick A.J., Trube G., Corrigall W.A., Huwyler J., Malherbe P., Wyler R., Higgins G.A. Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. Journal of Pharmacology and Experimental Therapeutics. 294:2000a;1112-1119
13. Grottick A.J., Wyler R., Higgins G.A. The alpha4beta2 agonist SIB 1765F, but not the alpha7 agonist AR-R 17779, cross-sensitises to the psychostimulant effects of nicotine. Psychopharmacology. 150:2000b;233-236
14. Hariharan M., VanNoord T. Liquid-chromatographic determination of nicotine and cotinine in urine from passive smokers: comparison with gas chromatography with a nitrogen-specific detector. Clinical Chemistry. 37:1991;1276-1280
15. Hariharan M., VanNoord T., Greden J.F. A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clinical Chemistry. 34:1988;724-729
16. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Research - Brain Research Reviews. 16:1991;223-244
17. Kempsill F.E., Pratt J.A. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine. British Journal of Pharmacology. 131:2000;997-1003
18. King S.L., Marks M.J., Grady S.R., Caldarone B.J., Koren A.O., Mukhin A.G., Collins A.C., Picciotto M.R. Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. Journal of Neuroscience. 23:2003;3837-3843
19. Klink R., de Kerchove d'Exaerde A., Zoli M., Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. Journal of Neuroscience. 21:2001;1452-1463
20. Ksir C., Hakan R.L., Kellar K.J. Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology (Berlin). 92:1987;25-29
21. Louis M., Clarke P.B. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology. 37:1998;1503-1513
22. Mansvelder H.D., Keath J.R., McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron. 33:2002;905-919
23. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., de Kerchove d'Exaerde A., Huchet M., Damaj M.I., Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 398:1999;805-810
24. Marubio L.M., Gardier A.M., Durier S., David D., Klink R., Arroyo-Jimenez M.M., McIntosh J.M., Rossi F., Champtiaux N., Zoli M., Changeux J.P. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. European Journal of Neuroscience. 17:2003;1329-1337
25. Olausson P., Engel J.A., Soderpalm B. Behavioral sensitization to nicotine is associated with behavioral disinhibition; counteraction by citalopram. Psychopharmacology. 142:1999;111-119
26. O'Neill M.F., Dourish C.T., Iversen S.D. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology. 104:1991;343-350
27. Panagis G., Nisell M., Nomikos G.G., Chergui K., Svensson T.H. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Research. 730:1996;133-142
28. Pauly J.R., Grun E.U., Collins A.C. Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone. Psychopharmacology. 108:1992;33-39
29. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature. 391:1998;173-177
30. Pietila K., Ahtee L. Chronic nicotine administration in the drinking water affects the striatal dopamine in mice. Pharmacology, Biochemistry and Behavior. 66:2000;95-103
31. Reavill C., Stolerman I.P. Locomotor activity in rats after administration of nicotinic agonists intracerebrally. British Journal of Pharmacology. 99:1990;273-278
32. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research - Brain Research Reviews. 18:1993;247-291
33. Roth, B.L., Craigo, S.C., Choudhary, M.S., Uluer, A., Monsma Jr., F.J., Shen, Y., Meltzer, H.Y., Sibley, D.R., 1994. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. Journal of Pharmacology and Experimental Therapeutics 268, 1403-1410.
34. Sparks J.A., Pauly J.R. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology. 141:1999;145-153
35. US Department of Health and Human Services, 1988. The health consequences of smoking. Nicotine Addiction. A Report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health DHHS Publication No. (CDC) 88-8406, Rockville, MD.
36. Waters N.S., Badura L.L., Ahmed S.A., Gogal R.M. Jr, Denenberg V.H. Manipulation of behavioral disorders in autoimmune mice via prolactin. Physiology and Behavior. 62:1997;983-988
37. Wooltorton J.R., Pidoplichko V.I., Broide R.S., Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. Journal of Neuroscience. 23:2003;3176-3185
38. Zoli M., Moretti M., Zanardi A., McIntosh J.M., Clementi F., Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. Journal of Neuroscience. 22:2002;8785-8789